Drug Shortage Report for ATROPINE SULFATE INJECTION USP

Last updated on 2020-03-10 History
Report ID 86516
Drug Identification Number 00328154
Brand name ATROPINE SULFATE INJECTION USP
Common or Proper name Atropine Sulfate Injection USP
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) ATROPINE SULFATE
Strength(s) 0.1MG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Packaging size 10 x 10mL LifeShield
ATC code A03BA
ATC description BELLADONNAAND DERIVATIVES, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-06-11
Estimated end date
Actual end date 2020-03-09
Shortage status Resolved
Updated date 2020-03-10
Company comments
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v14 2020-03-10 French Compare
v13 2020-03-10 English Compare
v12 2020-02-19 French Compare
v11 2020-02-19 English Compare
v10 2020-01-15 French Compare
v9 2020-01-15 English Compare
v8 2019-12-04 French Compare
v7 2019-12-04 English Compare
v6 2019-12-04 French Compare
v5 2019-12-04 English Compare
v4 2019-09-04 French Compare
v3 2019-09-04 English Compare
v2 2019-06-12 French Compare
v1 2019-06-12 English Compare